India to Netherlands: Atovaquone Export Trade Route
India has recorded 8 verified shipments of Atovaquone exported to Netherlands, representing a combined trade value of $235.0K USD. This corridor is served by 2 active Indian exporters, with an average shipment value of $29.4K USD. The leading Indian exporter is HETERO LABS LIMITED, which accounts for 80% of total export value with 7 shipments worth $187.5K USD. On the buying side, XXAROXXPHAXXA GXXH is the largest importer in Netherlands with $140.1K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Netherlands Atovaquone corridor is one of India's established pharmaceutical export routes, with 8 shipments documented worth a combined $235.0K USD. The route is dominated by HETERO LABS LIMITED, which alone accounts for roughly 80% of all export value, reflecting the consolidated nature of India's atovaquone manufacturing sector.
Across 2 active suppliers, the average shipment value stands at $29.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with atovaquone's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 20 days port-to-port. The route has recorded an annual growth rate of 23.8%, placing it at rank #9 among India's top atovaquone export destinations globally.
On the import side, key buyers of Indian atovaquone in Netherlands include XXAROXXPHAXXA GXXH, CENTRAFARM SERVICES ALLOGA NL B V, XXAROXXPHAXXA BXX. XXAROXXPHAXXA GXXH is the single largest importer with 5 shipments valued at $140.1K USD.
Route Characteristics
- Average transit20 days
